Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)

Clinical trial NCT00623558 · COMPLETED

Trial details

NCT number: NCT00623558
Sponsor: Seoul National University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasm

Start date: 2008-04-01
Primary completion: 2012-11-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.